Showing 16,941 - 16,960 results of 27,784 for search '(( 5 ((026 decrease) OR (nn decrease)) ) OR ( 50 ((c decrease) OR (a decrease)) ))', query time: 0.94s Refine Results
  1. 16941

    Table_3_Dose of Alcohol From Beer Required for Acute Reduction in Arterial Stiffness.DOCX by Masato Nishiwaki (666290)

    Published 2020
    “…Arterial stiffness did not significantly change among all AFB and B25. However, B50, B100, and B200 caused a significant decrease in arterial stiffness for approximately 30–60 min: heart-brachial pulse wave velocity (B50: −4.5 ± 2.4%; B100: −3.4 ± 1.3%; B200: −8.1 ± 2.6%); brachial-ankle pulse wave velocity (B50: −0.6 ± 2.0%; B100: −3.3 ± 1.1%; B200: −9.3 ± 3.0%); heart-ankle pulse wave velocity (B50: −3.7 ± 0.3%; B100: −3.3 ± 0.9%; B200: −8.1 ± 2.7%); and cardio-ankle vascular index (B50: −4.6 ± 1.3%; B100: −5.6 ± 0.8%; B200: −10.3 ± 3.1%). …”
  2. 16942

    Table_1_Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus.docx by Limin Wang (87511)

    Published 2023
    “…</p>Clinical parameters<p>A significant decrease in fasting plasma glucose (8.22 ± 2.19 vs 6.87 ± 1.09 mmol/L), glycated serum protein [291.00 (264.00, 353.00) vs 275.00 (251.00, 342.50) μmol/L], hemoglobin A1c (7.39 ± 1.18 vs 7.12 ± 1.33%), body mass index (25.32 ± 2.99 vs 24.83 ± 2.95 kg/m<sup>2</sup>), systolic blood pressure (129.05 ± 17.51 vs 123.43 ± 14.82 mmHg), and urinary creatinine [158.40 (74.75, 219.15) vs 79.70 (56.25, 138.10) μmmol/kg] levels was noted after 30-day Cana monotherapy (P < 0.05).…”
  3. 16943

    DataSheet_1_Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus.xls by Limin Wang (87511)

    Published 2023
    “…</p>Clinical parameters<p>A significant decrease in fasting plasma glucose (8.22 ± 2.19 vs 6.87 ± 1.09 mmol/L), glycated serum protein [291.00 (264.00, 353.00) vs 275.00 (251.00, 342.50) μmol/L], hemoglobin A1c (7.39 ± 1.18 vs 7.12 ± 1.33%), body mass index (25.32 ± 2.99 vs 24.83 ± 2.95 kg/m<sup>2</sup>), systolic blood pressure (129.05 ± 17.51 vs 123.43 ± 14.82 mmHg), and urinary creatinine [158.40 (74.75, 219.15) vs 79.70 (56.25, 138.10) μmmol/kg] levels was noted after 30-day Cana monotherapy (P < 0.05).…”
  4. 16944

    DataSheet_3_Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus.xls by Limin Wang (87511)

    Published 2023
    “…</p>Clinical parameters<p>A significant decrease in fasting plasma glucose (8.22 ± 2.19 vs 6.87 ± 1.09 mmol/L), glycated serum protein [291.00 (264.00, 353.00) vs 275.00 (251.00, 342.50) μmol/L], hemoglobin A1c (7.39 ± 1.18 vs 7.12 ± 1.33%), body mass index (25.32 ± 2.99 vs 24.83 ± 2.95 kg/m<sup>2</sup>), systolic blood pressure (129.05 ± 17.51 vs 123.43 ± 14.82 mmHg), and urinary creatinine [158.40 (74.75, 219.15) vs 79.70 (56.25, 138.10) μmmol/kg] levels was noted after 30-day Cana monotherapy (P < 0.05).…”
  5. 16945

    DataSheet_2_Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus.xls by Limin Wang (87511)

    Published 2023
    “…</p>Clinical parameters<p>A significant decrease in fasting plasma glucose (8.22 ± 2.19 vs 6.87 ± 1.09 mmol/L), glycated serum protein [291.00 (264.00, 353.00) vs 275.00 (251.00, 342.50) μmol/L], hemoglobin A1c (7.39 ± 1.18 vs 7.12 ± 1.33%), body mass index (25.32 ± 2.99 vs 24.83 ± 2.95 kg/m<sup>2</sup>), systolic blood pressure (129.05 ± 17.51 vs 123.43 ± 14.82 mmHg), and urinary creatinine [158.40 (74.75, 219.15) vs 79.70 (56.25, 138.10) μmmol/kg] levels was noted after 30-day Cana monotherapy (P < 0.05).…”
  6. 16946

    Oxygen concentration in the respiration chamber. by Pernille Nielsen (4249918)

    Published 2020
    “…Linear regression lines, regression equations and R<sup>2</sup> are given on the figure. The theoretical decrease in oxygen concentration in the respiration chamber (broken lines) calculated for the highest oxygen consumption (0.8 mg O<sub>2</sub> h<sup>-1</sup> g<sup>-1</sup>) from literature ([<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0230176#pone.0230176.ref049" target="_blank">49</a>,<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0230176#pone.0230176.ref050" target="_blank">50</a>] and for the lowest (0.13 mg O<sub>2</sub> h<sup>-1</sup> g<sup>-1</sup>) [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0230176#pone.0230176.ref048" target="_blank">48</a>].…”
  7. 16947

    CARDIOVASCULAR RESPONSES AFTER ISOMETRIC HANDGRIP EXERCISE AT DIFFERENT INTENSITIES IN HEALTHY MEN by Igor Marcelino da Silva (6674021)

    Published 2019
    “…None of the experimental sessions promoted statistically significant changes in systolic and diastolic BP (p> 0.05 for all). After S50, there was a smaller increase in SDNN five minutes after the exercise (S50: +5±6, S30: +20±5, SC: +10±2 ms, p <0.05) and higher LF/HF after 20 minutes (S50: +1.59±0.80, S30: -0.49±0.49, SC: +0.39±0.49, p <0.05) compared to the other sessions. …”
  8. 16948

    Ketamine reduces cell adhesion. by Claire E. Hills (452020)

    Published 2013
    “…<p>AFM-single-cell force spectroscopy was used to measure the detachment energy (fJoules) and maximum unbinding force (nN) required to uncouple two HK2 cells. The energy required to separate the cells; grey area in panel A (control cells), panel B (0.1 mg/mL Ketamine treated cells), panel C (0.5 mg/mL Ketamine treated cells), and panel D (1 mg/mL Ketamine treated cells), and maximum force of detachment (red circle) was measured. …”
  9. 16949

    S4 Dataset - by Shinichi Chisada (15354141)

    Published 2023
    “…Our results revealed that the medaka <i>rad50</i> mutation concurrently reproduced tumorigenesis (8 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka), had a decrease in median survival time (65.7 ± 1.1 weeks in control vs. 54.2 ± 2.6 weeks in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka, <i>p</i> = 0.001, Welch’s <i>t</i>-test), exhibited semi-lethality in <i>rad50</i><sup><i>Δ2/Δ2</i></sup> medaka and most of the major ataxia-telangiectasia phenotypes, including ataxia (rheotaxis ability was lower in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka than in the control, Mann–Whitney U test, <i>p</i> < 0.05), and telangiectasia (6 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka). …”
  10. 16950

    S1 Dataset - by Shinichi Chisada (15354141)

    Published 2023
    “…Our results revealed that the medaka <i>rad50</i> mutation concurrently reproduced tumorigenesis (8 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka), had a decrease in median survival time (65.7 ± 1.1 weeks in control vs. 54.2 ± 2.6 weeks in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka, <i>p</i> = 0.001, Welch’s <i>t</i>-test), exhibited semi-lethality in <i>rad50</i><sup><i>Δ2/Δ2</i></sup> medaka and most of the major ataxia-telangiectasia phenotypes, including ataxia (rheotaxis ability was lower in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka than in the control, Mann–Whitney U test, <i>p</i> < 0.05), and telangiectasia (6 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka). …”
  11. 16951

    S3 Dataset - by Shinichi Chisada (15354141)

    Published 2023
    “…Our results revealed that the medaka <i>rad50</i> mutation concurrently reproduced tumorigenesis (8 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka), had a decrease in median survival time (65.7 ± 1.1 weeks in control vs. 54.2 ± 2.6 weeks in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka, <i>p</i> = 0.001, Welch’s <i>t</i>-test), exhibited semi-lethality in <i>rad50</i><sup><i>Δ2/Δ2</i></sup> medaka and most of the major ataxia-telangiectasia phenotypes, including ataxia (rheotaxis ability was lower in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka than in the control, Mann–Whitney U test, <i>p</i> < 0.05), and telangiectasia (6 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka). …”
  12. 16952

    S2 Dataset - by Shinichi Chisada (15354141)

    Published 2023
    “…Our results revealed that the medaka <i>rad50</i> mutation concurrently reproduced tumorigenesis (8 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka), had a decrease in median survival time (65.7 ± 1.1 weeks in control vs. 54.2 ± 2.6 weeks in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka, <i>p</i> = 0.001, Welch’s <i>t</i>-test), exhibited semi-lethality in <i>rad50</i><sup><i>Δ2/Δ2</i></sup> medaka and most of the major ataxia-telangiectasia phenotypes, including ataxia (rheotaxis ability was lower in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka than in the control, Mann–Whitney U test, <i>p</i> < 0.05), and telangiectasia (6 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka). …”
  13. 16953

    S5 Dataset - by Shinichi Chisada (15354141)

    Published 2023
    “…Our results revealed that the medaka <i>rad50</i> mutation concurrently reproduced tumorigenesis (8 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka), had a decrease in median survival time (65.7 ± 1.1 weeks in control vs. 54.2 ± 2.6 weeks in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka, <i>p</i> = 0.001, Welch’s <i>t</i>-test), exhibited semi-lethality in <i>rad50</i><sup><i>Δ2/Δ2</i></sup> medaka and most of the major ataxia-telangiectasia phenotypes, including ataxia (rheotaxis ability was lower in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka than in the control, Mann–Whitney U test, <i>p</i> < 0.05), and telangiectasia (6 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka). …”
  14. 16954

    Stable swimming of wildtype. by Shinichi Chisada (15354141)

    Published 2023
    “…Our results revealed that the medaka <i>rad50</i> mutation concurrently reproduced tumorigenesis (8 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka), had a decrease in median survival time (65.7 ± 1.1 weeks in control vs. 54.2 ± 2.6 weeks in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka, <i>p</i> = 0.001, Welch’s <i>t</i>-test), exhibited semi-lethality in <i>rad50</i><sup><i>Δ2/Δ2</i></sup> medaka and most of the major ataxia-telangiectasia phenotypes, including ataxia (rheotaxis ability was lower in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka than in the control, Mann–Whitney U test, <i>p</i> < 0.05), and telangiectasia (6 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka). …”
  15. 16955

    Unstable swimming of mutant. by Shinichi Chisada (15354141)

    Published 2023
    “…Our results revealed that the medaka <i>rad50</i> mutation concurrently reproduced tumorigenesis (8 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka), had a decrease in median survival time (65.7 ± 1.1 weeks in control vs. 54.2 ± 2.6 weeks in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka, <i>p</i> = 0.001, Welch’s <i>t</i>-test), exhibited semi-lethality in <i>rad50</i><sup><i>Δ2/Δ2</i></sup> medaka and most of the major ataxia-telangiectasia phenotypes, including ataxia (rheotaxis ability was lower in <i>rad50</i><sup><i>Δ2/+</i></sup> medaka than in the control, Mann–Whitney U test, <i>p</i> < 0.05), and telangiectasia (6 out of 10 <i>rad50</i><sup><i>Δ2/+</i></sup> medaka). …”
  16. 16956

    MO-SAM segmentation performance using the Grid method in arid/semi-arid landscape. by Qitong Wang (15279695)

    Published 2025
    “…The point prompts, annotations, pixel intervals, and predictions are shown in light blue and the PI is 50, 35, 20; the IoU scores from left to right are 83.99, 81.05, and 44.19 percent, indicating a decrease in performance as the number and density of gridded point prompts increases In the third row, Platinum Group Elements, the point prompts, annotations, pixel intervals, and predictions are shown in purple. …”
  17. 16957

    Age-dependent changes in biometrics indicate senescence in the European Blackbird <i>Turdus merula</i> by Piotr Piliczewski (5277803)

    Published 2018
    “…<p><b>Capsule:</b> A 19-year study of European Blackbirds <i>Turdus merula</i> confirms that senescence is associated with a decrease in condition measured by wing length but bills become progressively longer with age.…”
  18. 16958

    Histological staining of the nerve three days after the surgery. by Bo Ra Kim (9662570)

    Published 2020
    “…<p>(A) Double staining of neurofilament (NF) and p75<sup>NTR</sup> (scale bar, 50μm). …”
  19. 16959

    Supplementary file 2_Impact of NF-κB and reactive oxygen species on intracellular BAFF/APRIL expression in ANCA-associated vasculitis: focusing on the effect of resveratrol.docx by Yasuhiro Shimojima (4615840)

    Published 2025
    “…Patients with AAV showed a significant decrease in APRIL expression without significant changes in BAFF expression in CD14+ cells treated with tempol; whereas there was a significant decrease in BAFF and APRIL expression in CD14+ cells treated with SN50. …”
  20. 16960

    Supplementary file 1_Impact of NF-κB and reactive oxygen species on intracellular BAFF/APRIL expression in ANCA-associated vasculitis: focusing on the effect of resveratrol.pptx by Yasuhiro Shimojima (4615840)

    Published 2025
    “…Patients with AAV showed a significant decrease in APRIL expression without significant changes in BAFF expression in CD14+ cells treated with tempol; whereas there was a significant decrease in BAFF and APRIL expression in CD14+ cells treated with SN50. …”